Clinical and Radiologic Assessments to Predict Breast Cancer Pathologic Complete Response to Neoadjuvant Chemotherapy

By Schott Anne  

Breast Cancer Research and Treatment, Vol. 92, Iss. 3, 2005-08 ,pp. : 231-238

Springer Publishing Company

Access to resources Recommend Favorite

Progress in Evaluation of Pathologic Response to Neoadjuvant Chemotherapy of Breast Cancer

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 13, Iss. 2, 2013-02 ,pp. : 222-226

Bentham Science Publishers

Access to resources Recommend Favorite

Prospective randomized trial of 5-fluorouracil, doxorubicin, and cyclophosphamide (FAC) versus paclitaxel and FAC (TFAC) in patients with operable breast cancer: impact of taxane chemotherapy on locoregional control

By Albert Jeffrey  

Breast Cancer Research and Treatment, Vol. 128, Iss. 2, 2011-07 ,pp. : 421-427

Springer Publishing Company

Access to resources Recommend Favorite

Clinicopathological Evaluation of Preoperative Chemotherapy with Doxorubicin Plus Cyclophosphamide Followed by Paclitaxel for Locally Advanced Breast Cancer

By Miyake Tomohiro   Miyahara Shigeki   Fujii Koji   Masanori   Tanimura Manabu   Yamamura Kentarou   Tadokoro Kyoko   Nakamura Haruyo  

Japanese Journal of Cancer and Chemotherapy, Vol. 36, Iss. 3, 2009-03 ,pp. : 401-405

Sunmedia

Access to resources Recommend Favorite

A gene expression signature that predicts the therapeutic response of the basal-like breast cancer to neoadjuvant chemotherapy

By Lin Yiing  

Breast Cancer Research and Treatment, Vol. 123, Iss. 3, 2010-10 ,pp. : 691-699

Springer Publishing Company

Access to resources Recommend Favorite